SI-113

• CAT Number: I041199
• CAS Number: 1392816-46-4
• Molecular Formula: C23H24N6O
• Molecular Weight: 400.48
• Purity: ≥95%
• Synonyms: 2-[[1-[(E)-2-phenylethenyl]-4-(2-phenylethylamino)pyrazolo[3,4-d]pyrimidin-6-yl]amino]ethanol
• IUPAC Name: 2-[[1-[(Z)-2-phenylethenyl]-4-(2-phenylethylamino)pyrazolo[3,4-d]pyrimidin-6-yl]amino]ethanol
• InChI: InChI=1S/C23H24N6O/c30-16-14-25-23-27-21(24-13-11-18-7-3-1-4-8-18)20-17-26-29(22(20)28-23)15-12-19-9-5-2-6-10-19/h1-10,12,15,17,30H,11,13-14,16H2,(H2,24,25,27,28)/b15-12-
• InChIKey: LAOYAWHHLUVMFT-QINSGFPZSA-N
• SMILES: C1=CC=C(C=C1)CCNC2=C3C=NN(C3=NC(=N2)NCCO)/C=C\C4=CC=CC=C4

SI-113（Cat No.:I041199）is an investigational small molecule compound being developed for the treatment of autoimmune diseases, particularly those involving excessive inflammation. It works by targeting specific immune signaling pathways that drive the activation of immune cells responsible for tissue damage and chronic inflammation. SI-113 aims to modulate the immune response without suppressing it entirely, thereby reducing the risk of infections and other complications. Preclinical studies have shown promising results in conditions like rheumatoid arthritis. Ongoing clinical trials are assessing its safety, efficacy, and potential as a therapeutic alternative to traditional immunosuppressive therapies.